UK Companies House feature
INDIVIOR UK LIMITED
Profile
- Company number
- 07183451
- Status
- Active
- Incorporation
- 2010-03-09
- Last accounts made up
- 2024-12-31
- Account category
- FULL
- Primary SIC
- 21100
- Hubs
- UK Healthcare
Accounts
Pending extraction
No iXBRL extracted yet for this company.
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- PricewaterhouseCoopers LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“These financial statements are prepared using the going concern basis of accounting. The Company's business activities, together with the factors likely to affect its future development and position, are set out in the Business Review section of the Strategic Report on page 2. The Company has net assets of $416,237k (2023: $327,755k). The Directors intend to continue the business operations in the foreseeable future.”
Subsidiaries
- Indivior Canada Ltd · 100% held · Canada · Trading Company
- Indivior Deutschland GmbH · 100% held · Germany · Trading Company
- Indivior España S.L.U. · 100% held · Spain · Trading Company
- Indivior EU Limited · 100% held · England & Wales · Trading Company
- Indivior Europe Limited · 100% held · Ireland · Dormant Company
- Indivior France SAS · 100% held · France · Trading Company
- Indivior Israel Ltd · 100% held · Israel · Trading Company
- Indivior Italia S.r.l. · 100% held · Italy · Trading Company
- Indivior Nordics ApS · 100% held · Denmark · Trading Company
- Opiant Pharmaceuticals UK Limited · 100% held · England & Wales · Dormant Company
- Indivior Schweiz AG · 100% held · Switzerland · Trading Company
Significant events
- “Effective 1 January 2024, the functional currency of Indivior UK Limited changed from pound sterling to U.S. dollar (USD).”
- “In June 2024, development of the remaining Opiant UK pipeline project addressing cannabis-use disorder via nasal inhaler was discontinued.”
- “On 9 July 2024, the Group announced the discontinuation of marketing and promotion for PERSERIS.”
- “On 4 September 2024, Aelis Farma announced that its clinical Phase 2B study with AEF0117 in participants with cannabis use disorder did not demonstrate the anticipated results.”
- “During the first quarter of 2025, the Group identified an error in the methodology used to accrue for Indivior's share of the annual U.S. fee imposed on drug manufacturers ... resulting in Indivior UK Limited being overcharged by $9,500k relating to prior years.”
- “In August 2025, the Group announced actions related to an initiative intended to maximise the potential of Indivior PLC's business...”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
3 active · 26 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| GIVENS, Alice Grace | Secretary | 2025-10-29 | — | — |
| CAIRNS, Graham | Director | 2023-11-01 | Nov 1970 | British |
| RUPANI, Bansari | Director | 2021-12-31 | Oct 1966 | British |
Show 26 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| DATHI, Cassie | Secretary | 2025-05-08 | 2025-10-29 |
| EMETULU, Lola Oloyade | Secretary | 2014-04-24 | 2015-06-15 |
| HUDSON, Kathryn Barbara | Secretary | 2015-06-15 | 2025-05-08 |
| RICHARDSON, Elizabeth Anne | Secretary | 2010-03-09 | 2014-04-24 |
| AMER, Bassel Antoine | Director | 2023-05-23 | 2023-10-04 |
| ARMSTRONG, David Frank | Director | 2010-03-09 | 2013-03-31 |
| BEARD, Katherine Julie | Director | 2018-11-19 | 2019-08-23 |
| BOJKOVSKY, Jozef | Director | 2015-02-19 | 2017-12-31 |
| CROSSLEY, Mark Wesley | Director | 2012-03-08 | 2015-02-19 |
| D'ANGELO, Massimo | Director | 2018-06-01 | 2024-12-31 |
| DAY, Colin Richard | Director | 2010-03-09 | 2011-02-08 |
| DOHERTY, Mary Elizabeth | Director | 2011-02-08 | 2013-02-12 |
| FOUCHE, Nicolas Pierre Jean Marie, Mr. | Director | 2024-12-31 | 2025-12-17 |
| GAWMAN, Andrew James | Director | 2011-02-08 | 2018-11-07 |
| GIBSON, Martyn George Alexander | Director | 2011-02-08 | 2012-03-08 |
| JAMESON, Richard Major | Director | 2013-03-01 | 2015-12-14 |
| PICARD, Gilles | Director | 2016-05-01 | 2023-05-02 |
| RIMIKIS, Michael | Director | 2015-02-19 | 2018-06-01 |
| ROBSON, James Richard | Director | 2010-03-09 | 2011-02-11 |
| SEHGAL, Sunil | Director | 2011-02-08 | 2014-12-19 |
| SHANK, Ms Amei W | Director | 2015-02-19 | 2019-12-31 |
| SHEPPARD, Abigail Christine | Director | 2021-12-31 | 2025-12-15 |
| SIMKIN, Richard | Director | 2015-02-19 | 2025-05-09 |
| STIER, Frank | Director | 2015-12-14 | 2020-04-01 |
| WEIS, Thomas | Director | 2018-11-07 | 2021-12-31 |
| WEST, Hillel Philip | Director | 2020-04-01 | 2025-12-15 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Rbp Global Holdings Limited | Corporate entity | Shares 75–100% | 2016-04-06 | Active |
Filing timeline
Last 20 of 161 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2026-03-31 | MR04 | mortgage | mortgage satisfy charge full |
| 2026-03-31 | MR04 | mortgage | mortgage satisfy charge full |
| 2026-03-31 | MR04 | mortgage | mortgage satisfy charge full |
| 2026-03-31 | MR04 | mortgage | mortgage satisfy charge full |
| 2026-03-31 | MR04 | mortgage | mortgage satisfy charge full |
| 2026-01-29 | PSC05 | persons-with-significant-control | change to a person with significant control |
| 2025-12-18 | TM01 | officers | termination director company with name termination date |
| 2025-12-15 | TM01 | officers | termination director company with name termination date |
| 2025-12-15 | TM01 | officers | termination director company with name termination date |
| 2025-10-29 | AP03 | officers | appoint person secretary company with name date |
| 2025-10-29 | TM02 | officers | termination secretary company with name termination date |
| 2025-10-22 | MR04 | mortgage | mortgage satisfy charge full |
| 2025-09-16 | AA | accounts | accounts with accounts type full |
| 2025-06-18 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2025-05-21 | AP03 | officers | appoint person secretary company with name date |
| 2025-05-21 | TM02 | officers | termination secretary company with name termination date |
| 2025-05-09 | TM01 | officers | termination director company with name termination date |
| 2025-02-20 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2025-01-07 | TM01 | officers | termination director company with name termination date |
| 2025-01-07 | AP01 | officers | appoint person director company with name date |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Credit score requires extracted accounts data.
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory
Activity Score not yet computed for this company.